CODX vs KMB · rev $3.9M vs P/E 19, rev $20.06B
Co-Diagnostics, Inc. Common Stock (CODX) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
CODX currently screens at market cap $31.4M. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the CODX and KMB stock pages for the full models.
Not investment advice.